Biohit

The GastroPanel test is being piloted in the UK to shorten waiting lists.

A new article links Acetium as part of GastroPanel testing and supports the commercialization of the product.

Proton pump inhibitors do not affect the accuracy of the GastroPanel Quick Test.

Biohit's reported earnings were excellent, but cash flowed out of the company in the first half of the year.

Chile's screening program accelerates revenue growth to 8% in our H1 estimate.

The stock's valuation has fallen to a rather low level.

Endoscopy wait times were reduced by 87%.